HDDO-1614 Bio Equivalence Study

Clinical trial NCT03382314 · COMPLETED

Trial details

NCT number

NCT03382314

Sponsor

Hyundai Pharmaceutical Co., LTD.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-10-16

Primary completion

2017-12-21

Enrollment

38

View on ClinicalTrials.gov